[Clinical, biochemical and molecular characteristics in 11 Czech children with tyrosinemia type I].

Early diagnostics of HT1 as a part of extended newborn screening is the only possibility to further improve the prognosis of the patients. Moreover, available molecular-genetic analysis of the FAH gene enables prenatal diagnostics in affected families.